IRB Number
|
#2003-373
|
| Description |
This research study will evaluate
the safety and effectiveness of a research medication for reducing the risk
of prostate cancer. Participants will receive either the active research
medication or placebo (inactive substance). |
| What is expected of me? |
Volunteers will first come in for
a screening visit and later for randomization to treatment. Participants
will return to the study center for visits every 6 months over the 4 years
that they participate in the study. Telephone contact will occur every 3
months to find out if you have had any changes in your health or
medications. |
| Inclusion Criteria |
Males, 50 – 75 years of age, negative prostate biopsy within 6 months or
willingness to have on done |
| Exclusion Criteria |
History of prostate cancer, previous prostate surgery, unstable medical
conditions, steroids or drug use within the past 12 months |
| Length of Study |
4 years |
| Study Location |
Penn State Milton S. Hershey
Medical Center |
| Investigator Information |
Carl Reese, M.D.
Department of Urology / Surgery |
| To obtain more information about this study please contact: |
Sue Worley, RN
717-531-8848
sworley@psu.edu |
